Christine D.

Christine D. has over 10 years of work experience in the fields of biotechnologies, business consulting, pharmaceuticals, marketing, medical research, and drug development. In 2018, they became the CBO & Co-Founder of Algen Biotechnologies. From 2015 to 2018, they were a Business Consultant at ZS. From 2014 to 2015, they were an Experienced Commercial Leadership Program at Janssen, Pharmaceutical Companies of Johnson and Johnson, where they defined key business objectives for 3 key brands and integrated external managed care data to create quantitative brand and portfolio performance dashboards. From 2010 to 2014, they were a Sr. Global Marketing Executive at Corum Inc., where they spearheaded the company's strategic plans, client management, legal and regulatory reviews and approval processes, and technical investments. From 2008 to 2010, they were a Dermatology Microbiome Researcher at the David Geffen School of Medicine at UCLA, where they co-authored a paper with 598 citations. From 2007 to 2008, they were a Drug Development Researcher at Johnson & Johnson.

Christine D. obtained their Bachelor of Science in Biochemistry from the University of California, Los Angeles. Christine then completed a Master in Biotechnology from Columbia University. Finally, they earned a Master of Business Administration (M.B.A.) in Health Care Management from The Wharton School in 2015. Additionally, Christine D. is a CFA Level 2 Candidate from the CFA Institute.